Intellectual Property and Antitrust Antitrust Basics Lesson III: Intellectual Property November 8, 2006 Sean P. Gates Federal Trade Commission.

Slides:



Advertisements
Similar presentations
GREETINGS TO CHARTERED ACCOUNTANTS FOR ICAIS POST QUALIFICATION COURSE VIDEO CONFERENCE FROM HYDERABAD 26 AUGUST 2005.
Advertisements

IP MISUSE and ANTITRUST LAW Eugene L. Chang January 9, 2009.
Ober | Kaler Exclusionary Practices in Healthcare May 25, 2010 William E. Berlin 202/ H Street, NW, Suite 500.
Slide 0 Refusals To License IP Jonathan I. Gleklen Partner Arnold & Porter The opinions expressed are those of the author and do not necessarily represent.
The Eighth Annual Trans- Atlantic Antitrust Dialogue Exclusionary Pricing in Article 82 Cases – A U.S. FTC Perspective Alden F. Abbott Associate Director,
Prof. David W. Opderbeck Seton Hall University Law School Gibbons Institute of Law, Science & Technology.
Trade-Offs by Harold Winter
© 2004 West Legal Studies in Business A Division of Thomson Learning 1 Chapter 46 Antitrust Law Chapter 46 Antitrust Law.
Slides developed by Les Wiletzky Wiletzky and Associates Copyright © 2006 by Pearson Prentice-Hall. All rights reserved. Antitrust Law.
1 COPYRIGHT © 2007 West Legal Studies in Business, a part of The Thomson Corporation. Thomson, the Star logo, and West Legal Studies in Business are trademarks.
National Judicial Academy National Conference for Newly Elevated High Court Justices January, 2015 Bhopal, India Samuel Weinstein Attorney Legal.
US Antitrust Limitations on Patent Licensing Bruce D. Sunstein Bromberg & Sunstein LLP Boston © 2008 Bromberg & Sunstein LLP.
Antitrust Counterclaims: The Basics Daniel M. Wall San Francisco
National symposium on Competition law: Evolution and Transition, 2012 Competition Policy for IP Issues Pradeep S Mehta Secretary General, CUTS International.
© 2007 by West Legal Studies in Business / A Division of Thomson Learning CHAPTER 20 Promoting Competition.
IP and Anticompetitive Conduct Intro to IP – Prof. Merges
1 Is there a conflict between competition law and intellectual property rights? Edward Whitehorn Head, Competition Affairs Branch Carrie Tang Assistant.
Antitrust Policy and Regulation Chapter 18 McGraw-Hill/Irwin Copyright © 2009 by The McGraw-Hill Companies, Inc. All rights reserved.
Chapter 47 Antitrust Law McGraw-Hill/Irwin Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved.
Sherman Act Section 2 Committee Hot Topics in Monopolization Law “Section 2 in the Antitrust Division” J. Bruce McDonald March 31, 2005 UNITED STATES DEPARTMENT.
Constructing the “Price” of the Technology in IP Licensing Negotiations Sub Regional Training Program on IP Valuation Maribor November 5 to 7, 2012.
London 22 Nov 2005 Modernization of Article 82 Lars-Hendrik Röller * Chief Competition Economist European Commission CLA and BIICL Conference on Article.
The Political, Legal, and Regulatory Environments of Global Marketing Chapter 5.
Law Antitrust - Instructor: Dwight Drake Brooke Group LTD v Williamson Tobacco (1993) Basic Facts: For 18 months, Brown Williams Tobacco (B&W) wages.
H I R S C H & P A R T N E R S A v o c a t S o l i c i t o r R e c h t s a n w a l t Pharmaceutical settlement agreements and competition law A litigation.
The FTC, Pharmaceuticals, Antitrust & IP: A Grab Bag October 23, 2008 This presentation was prepared from public sources. The views expressed herein do.
1 SECTION 337 INVESTIGATIONS Managing Intellectual Property IP In China April 30, 2013 New York, New York.
Antitrust. “Is there not a causal connection between the development of these huge, indomitable trusts and the horrible crimes now under investigation?
© Suzanne Scotchmer 2007 from Innovation and Incentives Licensing Some Terms: Exclusive Exclusive licensing versus exclusive dealing Royalties versus Fixed.
Can a Competition Law Violation be Legally Insignificant? A U.S. Perspective Russell W. Damtoft Associate Director Office of International Affairs United.
 “Market power” is the power of company to control the market for its product.  The law does allow for market monopolies when a patent is issued. During.
1 FRAND COMMITMENTS AND EU COMPETITION LAW Thomas Kramler European Commission, DG Competition (The views expressed are not necessarily those of the European.
© 2009 Prentice Hall Business Publishing Essentials of Economics Hubbard/O’Brien, 2e. Fernando & Yvonn Quijano Prepared by: Chapter 9 Monopoly and Antitrust.
© 2009 Prentice Hall Business Publishing Essentials of Economics Hubbard/O’Brien, 2e. Fernando & Yvonn Quijano Prepared by: Chapter 9 Monopoly and Antitrust.
Law Antitrust - Instructor: Dwight Drake Patent Pooling What is patent pooling? When is patent pooling anticompetitive? Can others be excluded from.
Constantine & Partners 1 Constantine Cannon 1 C C An Overview of the Antitrust/IP Intersect By Jeffrey I. Shinder Partner, Constantine Cannon New York.
1 Economic Analysis in Competition Law – A Lawyer’s Perspective A. Douglas Melamed March 23, 2009.
ABA China Inside and Out September , Beijing The interface between competition law and intellectual property Nicholas Banasevic, DG Competition,
 Federal gov may regulate business for any reason as long as advances gov economic need  States may regulate business as long as the laws do not interfere.
1 Hot Topics at the Interface of Intellectual Property and Competition Law Possible Antitrust Concerns Arising from Patent Pools ABA International Law.
© Hogan & Hartson LLP. All rights reserved. Monopoly Power: Getting it and keeping it US Perspective Sharis Pozen, Partner ACCE Seminar 13 May 2008.
EU Discussion Paper on Exclusionary Abuses Michael Albers European Commission DG Competition 54th Antitrust Law Spring Meeting Washington DC, 30 March.
Chapter 23 Antitrust Law and Unfair Trade Practices.
Willard K. Tom ABA Section of International Law Spring Meeting April 17, 2009 Compulsory Licensing: An Antitrust Lawyer’s Perspective.
1 The EC Competition Policy on Patent Pools. Has the Commission Struck the Right Balance? Paul Lugard Head of Antitrust Royal Philips ElectronicsABA Brown.
© 2004 West Legal Studies in Business A Division of Thomson Learning 1 Chapter 26 Antitrust and Monopoly.
Exercise of IP rights as an abusive behaviour under EU antitrust law Christian Vollrath European Commission DG Competition 1.
© 2004 West Legal Studies in Business, a Division of Thomson Learning 20.1 Chapter 20 Antitrust Law.
Identification of Abuse of dominant market position involving IPR Wang Xianlin, KoGoan Law School of Shanghai Jiaotong University Dalian,June 11,2010.
Review of the Transfer of Technology Block Exemption Regulation (TTBE) 2001 Report shortcomings of the TTBE new generation of regulations more economic.
Sangmin Song, Director, Anti-Monopoly Div., KFTC MRFTA & IP Rights 1.
Patent settlements for medicines -- status under EU and US antitrust law -- Luc Gyselen, Partner Arnold & Porter LLP Brussels Symposium on the Interface.
49-1 Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved.McGraw-Hill/Irwin.
Recent FTC Pharmaceutical Cases: Background and Examples Sue H. Kim This presentation was prepared from public sources. The views expressed herein do not.
Identification of Monopoly Agreement involving Intellectual Property Rights Wang Xianlin, KoGuan Law School of Shanghai Jiao Tong University Dalian, June.
 As an entrepreneur, there are laws that affect almost every aspect of your business.  Even the competition that business face is regulated by the government.
Dialogue on Competition Policy and Intellectual Property *
Intro to Intellectual Property 3.0
EU Competition Rules for Technology Transfer Agreements
Chapter 37 Antitrust Law.
Chapter 22 Promoting Competition.
Chapter 27: Antitrust and Monopoly
The new technology transfer regime More evolution than revolution
Class 21 Antitrust, Winter, 2018 Antitrust and Patents
“Revisiting Abuse of Dominance & IPRs: Emerging Jurisprudence of the Indian Competition Law” “Plenary 2: A comparative perspective to IPR and Competition:
The new technology transfer regime
US Antitrust Limitations on Patent Licensing
The 8th Annual Pharmaceutical Regulatory & Compliance Congress
Essentials of the legal environment today, 5e
Presentation transcript:

Intellectual Property and Antitrust Antitrust Basics Lesson III: Intellectual Property November 8, 2006 Sean P. Gates Federal Trade Commission

Disclaimer The views expressed here are mine alone and do not necessarily reflect the views of the Federal Trade Commission, any Commissioner, or other FTC staff. The views expressed here are mine alone and do not necessarily reflect the views of the Federal Trade Commission, any Commissioner, or other FTC staff.

Overview Introduction Introduction Basic assumptions Basic assumptions Analytical Framework Analytical Framework Open Issues Open Issues

Introduction Types of Intellectual Property Types of Intellectual Property Applicable Antitrust Laws Applicable Antitrust Laws

Types of Intellectual Property Patent: exclusive right to make, use, or sell a product or service embodying the invention Patent: exclusive right to make, use, or sell a product or service embodying the invention Copyright: exclusive right to reproduce, prepare derivative works, and distribute copyrighted material Copyright: exclusive right to reproduce, prepare derivative works, and distribute copyrighted material Trademark: exclusive right to use mark in commerce Trademark: exclusive right to use mark in commerce

Applicable Antitrust Laws Section 1: coordinated conduct Section 1: coordinated conduct –Licensing agreements –Patent pools Section 2: unilateral conduct Section 2: unilateral conduct –Refusals to license –Bad faith enforcement Section 7: acquisitions Section 7: acquisitions –Patent accumulation

Basic Assumptions Historical Views Historical Views Current US View Current US View International Views International Views

Historical Views IP and Antitrust are in conflict IP and Antitrust are in conflict Initial View: IP Prevails Over Antitrust Initial View: IP Prevails Over Antitrust Early View: Antitrust Must Limit IP to the Scope of the Grant Early View: Antitrust Must Limit IP to the Scope of the Grant

Initial View: IP “Trumps” Antitrust IP law gives “immunity” from antitrust IP law gives “immunity” from antitrust “Very object” of IP is to grant “monopoly” “Very object” of IP is to grant “monopoly” IP law therefore gave “absolute freedom” IP law therefore gave “absolute freedom”

Early View: Antitrust Must Limit IP Focus was on scope of IP grant Focus was on scope of IP grant Conduct inside scope was immune Conduct inside scope was immune Conduct outside scope was unlawful Conduct outside scope was unlawful

Current US View: 1995 IP Guidelines IP law and antitrust share common purpose: promoting innovation and enhancing consumer welfare IP law and antitrust share common purpose: promoting innovation and enhancing consumer welfare Antitrust analysis of IP like other property Antitrust analysis of IP like other property IP does not necessarily confer market power IP does not necessarily confer market power Licensing is generally procompetitive Licensing is generally procompetitive

International Views: Countries with Competition Laws: 1980 Source: ICN: Assessing Technical Assistance (2005)

Countries with Competition Laws: 2005 Source: ICN: Assessing Technical Assistance (2005)

International Convergence: EC Regulations (2004) Same “basic objective”: “promoting consumer welfare” Same “basic objective”: “promoting consumer welfare” IP not immune from competition law IP not immune from competition law Market power based on extent of substitutes Market power based on extent of substitutes Technology transfer agreements usually pro-competitive Technology transfer agreements usually pro-competitive

International Convergence: CCS Guidelines (2005) IP and competition laws both “promot[e] economic efficiency and innovation” IP and competition laws both “promot[e] economic efficiency and innovation” IP “essentially comparable” to “other property” IP “essentially comparable” to “other property” IP “does not necessarily create market power” IP “does not necessarily create market power” Licensing generally procompetitive Licensing generally procompetitive

Analytical Framework Key Questions Key Questions Applications Applications

Analytical Framework: What are the key questions? What is the competitive relationship between the parties? What is the competitive relationship between the parties? Do the parties have market power? Do the parties have market power? What is the mechanism of potential harm? What is the mechanism of potential harm? What are the procompetitive benefits? What are the procompetitive benefits?

What is the relationship between the parties? Horizontal v. vertical relationship Horizontal v. vertical relationship Are the parties actual or likely competitors? Are the parties actual or likely competitors? –depends on scope of IP –depends on relationship of IP

Do the parties have market power? Market power: the ability to profitably price above competitive level for significant period of time Market power: the ability to profitably price above competitive level for significant period of time No presumption No presumption Depends on availability of substitutes Depends on availability of substitutes Must define relevant market Must define relevant market

Market Power: in what relevant market? Goods market Goods market –Market for goods made using the IP and subs Technology market Technology market –Technologies and goods that are close economic substitutes Innovation market Innovation market –R&D to particular new goods or processes, and close substitutes for that R&D

What is the mechanism of potential harm? Limiting competition between parties Limiting competition between parties –market division –price fixing Limiting competition from others Limiting competition from others –exclusive dealing –tying –package licensing/ patent pools

What are the procompetitive benefits? Exclusive dealing Exclusive dealing –encourage investments and promotion Patent pools Patent pools –integrating complementary technologies –reducing transaction costs –clearing blocking positions –avoiding costly infringement litigation

Application: Cross-license with Territorial Market Division

Cross-license with Territorial Market Division Competitive relationship? Competitive relationship? –are the patents blocking? –are the patents complementary? Market power? Market power? Mechanism of potential harm? Mechanism of potential harm? –agreement not to compete What are the procompetitive benefits? What are the procompetitive benefits? –integrating complementary resources?

Application: Exclusive Dealing

Exclusive Dealing Competitive relationship? Competitive relationship? –vertical or horizontal? Market power? Market power? Mechanism of potential harm? Mechanism of potential harm? –foreclosure of competitors –foreclose licensee internal development What are the procompetitive benefits? What are the procompetitive benefits? –encourage investment or promotion

Open Issues Refusals to license Refusals to license Proving market power Proving market power “Reverse Payment” Settlements of IP Litigation “Reverse Payment” Settlements of IP Litigation

Open Issues: Refusals to License US View US View –In re ISO Antitrust Litigation (Xerox), 203 F.3d 1322 (Fed. Cir. 2000) –Image Technical Services, Inc. v. Eastman Kodak Co., 125 F.3d 1195 (9th Cir. 1997) EC view EC view –DG Comp Article 82 Discussion Paper

Refusals to License: Underlying Issues Relationship between IP and innovation Relationship between IP and innovation –Does strong IP foster innovation? –Will requiring licensing in certain circumstances diminish incentives? –Does the answer depend on the industry?

Open Issues: Proving Market Power or How do we know a patent is blocking? “[O]nly the legal force of the [patents] themselves … can exclude competitors, and patent claim interpretation is… to be decided by the courts” Minebea v. Papst, _ F. Supp. 2d _, 2006 WL (D.D.C. Aug. 17, 2006) “[O]nly the legal force of the [patents] themselves … can exclude competitors, and patent claim interpretation is… to be decided by the courts” Minebea v. Papst, _ F. Supp. 2d _, 2006 WL (D.D.C. Aug. 17, 2006) In re Union Oil Co. of Cal., 2004 FTC Lexis 115, 127 (2004) (market power could be established through evidence of business conduct and responses to threats and suits). In re Union Oil Co. of Cal., 2004 FTC Lexis 115, 127 (2004) (market power could be established through evidence of business conduct and responses to threats and suits).

Market Power Issue: Cross-license with Territorial Market Division

Open Issue: “Reverse Payment” Settlements of IP Litigation Judicial treatment Judicial treatment Open analytical issues Open analytical issues

“Reverse Payment” Cases in the Courts of Appeals Decisions from Sixth, Eleventh and Second Circuits Decisions from Sixth, Eleventh and Second Circuits Sixth Circuit: Applied per se test. Sixth Circuit: Applied per se test. –In re Cardizem CD Antitrust Litigation, 332 F.3d 896 (6th Cir. 2003)

“Reverse Payment” Cases in the Courts of Appeals Eleventh Circuit: Applied three-part test: Eleventh Circuit: Applied three-part test: –“potential exclusionary effect” of patent –extent the agreement exceeded scope –anticompetitive effects Valley Drug Co. v. Geneva Pharms., 403 F.3d 1056 (11th Cir. 2003) Valley Drug Co. v. Geneva Pharms., 403 F.3d 1056 (11th Cir. 2003) Schering-Plough Corp. v. FTC, 402 F.3d 1056 (11th Cir. 2005) Schering-Plough Corp. v. FTC, 402 F.3d 1056 (11th Cir. 2005) Andrx Pharms. v. Elan Corp., 421 F. 3d 1227 (11th Cir. 2005) Andrx Pharms. v. Elan Corp., 421 F. 3d 1227 (11th Cir. 2005)

“Reverse Payment” Cases in the Courts of Appeal Second Circuit: Generally followed logic of Eleventh Circuit. Second Circuit: Generally followed logic of Eleventh Circuit. In re Tamoxifen, _ F.3d _ (2d Cir. 2006) In re Tamoxifen, _ F.3d _ (2d Cir. 2006) –Settlement after patentee loss at district court not suspect –Reverse payment not suspicious so long as litigation not a sham –Restrictions within exclusionary scope –Agreement did not cause bottleneck

“Reverse Payment” Cases: District Court Kaiser Found. Health Plan v. Abbott Labs., CV JFW (C.D. Cal.) Kaiser Found. Health Plan v. Abbott Labs., CV JFW (C.D. Cal.) –Hytrin opt out –agreement deemed per se illegal –causation tried to jury would generic enter “but for” agreement would generic enter “but for” agreement –Jury verdict for defendants

“Reverse Payment” Cases: View of Patent Rights Probabalistic patent rights Probabalistic patent rights Commission’s Cert. Petition, FTC v. Schering-Plough: Commission’s Cert. Petition, FTC v. Schering-Plough: –“the ‘probabilistic’ nature of patents” –“As both economists and legal scholars have remarked, ‘a patent is not a right to exclude, but rather a right to try to exclude.’”

Conclusion Basic assumptions Basic assumptions –refined over time –international convergence Analytical Framework Analytical Framework –Key questions Open Issues Open Issues –Some key questions remain unresolved